Treating stubborn depression

October 3, 2012

At least one in three patients with depression won't respond well to a series of treatments and experts in the field have joined together to outline practical treatments to tackle the issue, in the Medical Journal of Australia Open.

can be a stubborn problem—at least one in three patients fail to respond to proven therapies—and experts in the field have put their heads together to outline practical treatment approaches for in an MJA Open supplement on "difficult-to-treat depression". "While GPs have many skills in the assessment and treatment of depression, they are often faced with people with depression who simply do not get better, despite the use of proven therapies, be they psychological or pharmacological", wrote Professor David Castle, Chair of Psychiatry at St Vincent's Health and the University of Melbourne, and coauthors.

They wrote that they hoped the approaches outlined in the supplement could assist clinicians—and GPs in particular—to improve the outcomes of patients with difficult-to-treat depression. In an article on pharmacological approaches to the problem, Dr Herng-Nieng Chan and Professor Philip Mitchell, with the University of and the Black Dog Institute, and coauthors outlined the latest evidence-based drug treatment strategies for people with difficult-to-treat depression, based on studies including a US trial of almost 3000 patients.

The US study found that 30% of patients failed to achieve of their depression after using up to four different antidepressants. "This finding reflects the reality of clinical practice and highlights the need to employ the best available evidence in the management of people with complex depression", they wrote.

Professor Paul Fitzgerald, a psychiatrist from Monash Alfred Centre, wrote that electroconvulsive therapy remained the most widely used and effective biological non-drug treatment for difficult-to-treat depression.

However, he also detailed innovative new forms of brain stimulation, including magnetic seizure therapy and vagus nerve stimulation, which showed promise. "Ongoing work is required to define which treatments are likely to be most useful, and in which patient groups", he wrote.

Dr Melissa Casey, director of psychology at Southern Health, and coauthors wrote that evidencebased psychological approaches including cognitive behaviour therapy, interpersonal psychotherapy and family-based therapy could improve outcomes in difficult-to-treat depression.

As thought patterns and behaviour played a large role in determining outcomes of treatment for people with depression, they wrote, they were "prime candidates for intervention through a psychosocial treatment regimen".

Explore further: Speech a new marker for depression treatment response

Related Stories

Speech a new marker for depression treatment response

August 13, 2012
(Medical Xpress) -- Speech can measure the severity of depression as well as a patient’s response to treatment, a new collaborative study between the University of Melbourne and the Center for Psychological Consultation ...

Looking at links between depression and insomnia

February 27, 2012
People with both insomnia and depression who have found anti-depressants ineffective can draw hope from a new study currently recruiting in Melbourne.

Online treatment dramatically cuts suicide risk

September 18, 2012
(Medical Xpress)—Australian research, published in the British Medical Journal Open, shows a dramatic reduction in both depression and suicidal thoughts in patients who participated in a study involving internet cognitive ...

Treating depression one step at a time

July 1, 2011
(Medical Xpress) -- One in six people worldwide will experience depression over the course of a lifetime. This alarming fact has led to recent research by Dr. Paul Biegler from the Center for Human Bioethics at Monash University. ...

Recommended for you

Scientists researching drugs that could improve brain function in people with schizophrenia

October 12, 2017
Virginia Commonwealth University researchers are testing if drugs known as HDAC inhibitors improve cognition in patients with schizophrenia who have been treated with the antipsychotic drug clozapine.

Researchers find a fine timeline between delusion and reality

October 12, 2017
The line between reality and delusion may be just a matter of time, a new Yale study suggests.

Virtual humans work better than current ways to identify post-traumatic stress in soldiers

October 12, 2017
Soldiers are more likely to open up about post-traumatic stress when interviewed by a virtual interviewer than by taking a survey, finds a study published today in open-access journal Frontiers in Robotics and AI. A computer-generated ...

Women seen as younger when eyes, lips and eyebrows stand out

October 11, 2017
Aspects of facial contrast, a measure of how much facial features stand out in the face, decrease with age in women across a variety of ethnic groups, finds a study in open access journal Frontiers in Psychology. The study ...

Voice-only communication more accurate than visual cues for identifying others' feelings, study says

October 10, 2017
If you want to know how someone is feeling, it might be better to close your eyes and use your ears: People tend to read others' emotions more accurately when they listen and don't look, according to research published by ...

Experts call for more rigor, less hype, for mindfulness and meditation

October 10, 2017
Dependable scientific evidence has lagged worrisomely behind the rapid and widespread adoption of mindfulness and meditation for pursuing an array of mental and physical wellness goals, wrote a group of 15 experts in a new ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.